Clinical Drug Development PGDip

    Clinical Drug Development PGDip

    Duration9 month(s)
    Tuition Fee
    GBP 14,793 / year(s)
    Next IntakeSeptember 1, 2026
    Clinical Drug Development PGDip

    About

    What you'll study

    We have developed a modular postgraduate programme in clinical drug development. It is designed to give you the academic background and specialist skills you need to carry out clinical drug development in a contract research organisation, pharmaceutical industry or health service environment.

    The modular nature of the programme is designed to fit in with your needs if you are in full-time employment. You will receive the taught element of the modules in three-day blocks every four to six weeks (approximately).

    Your initial modules will concentrate on early drug development. You will learn how to design a clinical study and gain insights into the practical aspects of early drug development. You will cover ethics and regulation and understand how to manage the data of a study. You will also gain a wider picture of drug discovery and pre-clinical research and development as well as toxicology.

    Clinical Drug Development programme is designed for individuals seeking deeper understanding and insight into the area of Clinical Drug Development, Clinical Trial design and Clinical Trial Management in the following key areas:

    • Drug Design
    • Pharmaceutical Analysis
    • Drug safety and pharmacovigilance
    • Clinical trial management e.g. (clinical research associates)
    • Pharmaco-economics
    • Marketing
    • Regulatory Affairs
    • Quality Assurance
    • Medical Sales

    Disciplines

    William Harvey Research Institute

    Requirements

    Entry Requirements

    Saudi Arabia
    We normally consider the following qualifications for entry to our postgraduate taught programmes: Bachelor Degree from a recognised institution.

    UK 1st class degree: GPA 4.75 out of 5.0; or GPA 3.75 out of 4.0
    UK 2:1 degree: GPA 3.75 out of 5.0; or GPA 3.0 out of 4.0
    UK 2:2 degree: GPA 3.0 out of 5.0; or GPA 2.4 out of 4.0

    English Requirements

    • PTEMin 68
    • IELTSMin 7
    • TOEFLMin 100

    English Program Requirements

    The English language requirements for our programmes are indicated by English bands, and therefore the specific test and score acceptable is based on the band assigned to the academic department within which your chosen course of study is administered. Note that for some academic departments there are programmes with non-standard English language requirements. The English Language requirements for entry to postgraduate taught and research programmes in the William Harvey Research Institute falls within the following English band: Band 4: IELTS (Academic) minimum score 6.5 overall with 6.0 in each of Writing, Listening, Reading and Speaking Please note, there are some postgraduate programmes with non-standard English language requirements in this Institute. We accept a range of English tests and qualifications categorised in our English bands for you to demonstrate your level of English Language proficiency. See all accepted English tests that we deem equivalent to these IELTS scores.

    Career

    Career paths

    This course is designed to give you the academic background and specialist skills you need to carry out clinical drug development in a contract research organisation, pharmaceutical industry or health service environment.

    Graduates from our Clinical Drug Development programmes have gone onto work for companies including Astra Zeneca, IQVIA, Labcorp, Medpace, Research Organization KC, Syneos; NHS organisations including NHS Lothian, Royal Marsden NHS Foundation Trust and University College London Hospitals NHS Foundation Trust; and other health organisations such as Infectious Diseases Data Observatory. Some also choose to continue their studies.

    Our recent graduates are working in roles such as clinical trials data manager, laboratory manager, data manager, research assistant, clinical trials associate and senior clinical trials associate.

    Source: Graduate Outcomes Survey 2021/22

    • 93% of WHRI graduates are in employment or further study (2021/22)
    • 89% of WHRI graduates in employment or study are in highly skilled work or graduate study (2021/22)

    Fee Information

    Tuition Fee
    14,793 / year(s)
    Clinical Drug Development PGDip
    Queen Mary University of London
    Queen Mary University of London
    United Kingdom

    United Kingdom, London

    Go to Official Website
    WhatsApp student consultation with YouApply